Lpl Financial LLC Pacira Bio Sciences, Inc. Transaction History

Lpl Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.5 - $31.51 $190,332 - $235,190	7,464 New	7,464 $213,000
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $169,711 - $221,230	6,448 New	6,448 $217,000
Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $26,312 - $39,583	-689 Reduced 10.13%	6,113 $236,000
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $35,304 - $40,575	-689 Reduced 9.2%	6,802 $362,000
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $3,964 - $6,286	77 Added 1.04%	7,491 $437,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $9,664 - $12,314	161 Added 2.22%	7,414 $566,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $49,553 - $64,262	1,033 Added 16.61%	7,253 $436,000
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $35,461 - $39,783	649 Added 11.65%	6,220 $348,000
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $124,337 - $147,048	2,101 Added 60.55%	5,571 $338,000
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $205,805 - $273,505	3,470 New	3,470 $243,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.